Risk factor
Strong trading liquidity
Profitability factor
Somewhat favourable analyst view
About
Yifan Pharmaceutical Co., Ltd. engages in the research, development, production, sale of pharmaceutical products, active pharmaceutical ingredients and polymer materials. It provides blood tumors, gynecology, pediatrics, skin, orthopedic drugs, phosphate buffered saline, polyvinyl butyral products, vitamin B5 and original B5. The company was founded on November 10, 2000 and is headquartered in Hangzhou, China.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'expensive' o
Target Price
The average target price of 002019.SZ is 13.0 and suggests 31.7% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to